Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06539429
PHASE1

Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L

Sponsor: Anterogen Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a phase I open study to evaluate the efficacy and safety of ANT-301 in patients with knee osteoarthritis K\&L Grade III/IV.

Official title: Phase I Clinical Study to Evaluate Safety and Efficacy of ANT-301 in Knee Osteoarthritis Patients

Key Details

Gender

All

Age Range

19 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2024-10-22

Completion Date

2026-05-15

Last Updated

2025-09-22

Healthy Volunteers

No

Interventions

BIOLOGICAL

ANT-301

Administration on Day 1

Locations (1)

Seoul National University

Seoul, Seoul, South Korea